NIH PAR · NCI · R01

PAR-25-338: Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards

Open for applicationsNext due date: Feb 5, 2027Expires Jan 8, 2028

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. The rationale is to deliver new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and delivery of care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating institutes.

Full NOFO in the NIH Guide Apply on Grants.gov

NOFO number
PAR-25-338
Type
PAR
Activity code
R01
Primary institute
NCI · National Cancer Institute
Clinical trials
Not Allowed
Posted
Dec 31, 2024
Opens
Jan 5, 2025
Expires
Jan 8, 2028

PAR-25-338 due dates

3 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.

Application due dates and review cycles for PAR-25-338
Application Due Date(s)Renewal / Resubmission / Revision (as allowed)AIDS - New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
February 05, 2025March 05, 2025 *Not ApplicableJuly 2025October 2025December 2025
June 05, 2025July 05, 2025 *Not ApplicableNovember 2025January 2026April 2026
October 05, 2025November 05, 2025 *Not ApplicableMarch 2026May 2026July 2026
February 05, 2026March 05, 2026 *Not ApplicableJuly 2026October 2026December 2026
June 05, 2026July 05, 2026 *Not ApplicableNovember 2026January 2027April 2027
October 05, 2026November 05, 2026 *Not ApplicableMarch 2027May 2027July 2027
February 05, 2027March 05, 2027 *Not ApplicableJuly 2027October 2027December 2027
June 05, 2027July 05, 2027 *Not ApplicableNovember 2027January 2028April 2028
October 05, 2027November 05, 2027 *Not ApplicableMarch 2028May 2028July 2028

Projects funded under PAR-25-338

NIH RePORTER lists 9 projects funded under PAR-25-338 in FY2022–FY2026, with $5.6M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.

Projects funded

9

Distinct projects, FY2022–FY2026

New awards

9

Type 1 (new project) award records

NIH funding

$5.6M

Award dollars under PAR-25-338, FY2022–FY2026

Funding by fiscal year

Award records, new awards, and funding by fiscal year under PAR-25-338
Fiscal yearAward recordsNew awardsFunding
FY202200$0
FY202300$0
FY202400$0
FY202500$0
FY202699$5.6M

Institutions with the most funding

  1. Johns Hopkins University$693K · 1 project
  2. Yale University$645K · 1 project
  3. Harvard University$641K · 1 project
  4. Washington University$563K · 1 project

Funding institutes

  • NCI$5.6M · 9

Activity codes funded

What its predecessor PAR-21-166 funded

PAR-25-338 reissues PAR-21-166. Its funding history is the best guide to who wins under this program: 24 projects and $50.6M in FY2022–FY2026.

Projects funded

24

Distinct projects, FY2022–FY2026

New awards

21

Type 1 (new project) award records

NIH funding

$50.6M

Award dollars under PAR-21-166, FY2022–FY2026

Funding by fiscal year

Award records, new awards, and funding by fiscal year under PAR-21-166
Fiscal yearAward recordsNew awardsFunding
FY202254$2.9M
FY2023106$5.9M
FY2024207$11.7M
FY2025254$15.5M
FY2026210$14.7M

Institutions with the most funding

  1. Johns Hopkins University$5.2M · 2 projects
  2. Dartmouth College$2.9M · 1 project

Funding institutes

  • NCI$50.1M · 80
  • NIBIB$531K · 1

Activity codes funded

  • R0177 records
  • R373 records
  • R561 record

FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.

Participating institutes

4 NIH institutes and offices take applications under PAR-25-338. Contact the program officer at the institute that fits your research before applying.

  • NCI · National Cancer Institute
  • NEI · National Eye Institute
  • NIDCR · National Institute of Dental and Craniofacial Research
  • ORWH

Related notices

  1. Mar 31, 2025

    This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.

  2. Jan 10, 2025 · NOT-CA-25-032

    Notice of Correction to PAR-25-338 Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment R01 - Clinical Trial Not Allowed). See Notice NOT-CA-25-032.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25,…

  3. Aug 31, 2022 · NOT-OD-22-198

    Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.

  4. Aug 5, 2022 · NOT-OD-22-189

    Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.

Award terms

Application types allowed
NewRenewalResubmissionRevision The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
Award budget
Application budgets are limited to 499,000 direct costs) per year.
Project period
The maximum project period is 5 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
Funds available and number of awards
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.

Related NOFOs

  • Reissue of PAR-21-166.
  • Companion NOFOs: PAR-25-337.

Other open NOFOs for R01

Browse all open NIH NOFOs

About this page

GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.

Find who wins under this NOFO